Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Prudential reaches settlement in Malaysian dividend dispute

(Sharecast News) - Prudential announced on Thursday that it has reached a full and final settlement in its legal dispute with Malaysian firm Detik Ria over dividend claims related to its joint venture in the country, bringing an end to proceedings that sought over $800m in payouts. The FTSE 100 company said Detik Ria, which holds a 49% stake in Sri Han Suria (SHS) - the holding company of Prudential Assurance Malaysia - had launched legal proceedings in April seeking dividends equivalent to about $833m plus interest.

Under the terms of the settlement, SHS would pay Detik Ria a dividend of $83m, funded from existing resources.

As part of the agreement, Prudential said it also waived a $33m receivable owed by Detik Ria to one of its subsidiaries, stemming from a prior Federal Court decision.

All legal proceedings would be withdrawn, and the parties agreed to a mutual release of liability for all historical claims.

The settlement was governed by the laws of England and Wales and subject to arbitration in Singapore.

Prudential said the unaudited financial impact of the agreement was expected to result in a small increase to IFRS shareholder equity.

Its group financial statements would continue to reflect a 49% non-controlling interest for Detik Ria in PAMB.

At 1213 BST, shares in Prudential were up 2.66% at 963.2p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.